Nav: Home

Immunology: How ancestry shapes our immune cells

June 01, 2017

Virtually the entire population of sub-Saharan Africa, and some 70% of African Americans, carry a gene variant (allele) which results in a trait referred to as Duffy-negative. It has long been known that carriers of this version of the gene are relatively protected from some strains of malaria. In addition, the allele has recently been linked to benign neutropenia -- a mild reduction in the numbers of neutrophilic granulocytes (neutrophils), a type of white blood cells present in the circulation. Although neutrophils are known to play an important part in the innate immune defenses against pathogens, Duffy-negative individuals do not show any obvious increase in susceptibility to infections. In a new study led by LMU's Dr. Johan Duchêne, Professor Christian Weber and Professor Antal Rot (also at University of York), an international team of biomedical researchers has now shown how the Duffy-negative variant affects the differentiation of white blood cells and why it leads to a relative paucity of circulating neutrophils. The findings appear in the current issue of the journal Nature Immunology.

All blood cell types are generated in the bone marrow. In a process called hematopoiesis, so-called multipotent hematopoietic stem cells and progenitor cells progressively give rise to the different types of cells found in the bloodstream. Among these are the neutrophils and the erythrocytes (aka red blood cells). Duffy-negative individuals lack a specific protein, the atypical chemokine receptor 1 (abbreviated ACKR1), normally found on the surface of the erythrocytes. ACKR1 is known to interact with signal molecules called chemokines that regulate immune responses. However, some pathogens responsible for malaria use this receptor to dock onto and subsequently invade red blood cells. This explains why people who lack this receptor are more resistant to some types of malaria. "But how the lack of ACKR1 on red blood cells alters the balance of white blood cell types was entirely unknown up to now," Duchêne says.

Using the mouse as an experimental model, Duchêne and his colleagues have now shown that the link between ACKR1 and the white blood cell population lies at the level of the differentiation of stem cells and precursor cells during hematopoiesis. The authors discovered that progenitors of the erythrocytes form a specific "niche" in the bone marrow and support the differentiation of hematopoietic stem cells. Thus, surprisingly the expression of ACKR1 on the surface of these erythrocyte progenitors determines the ultimate fates of the stem cells. "If the erythrocyte precursors do not express ACKR1, the stem cells differentiate into neutrophilic granulocytes that differ both molecularly and functionally from those formed following contacts with ACKR1," Duchêne explains. "Our results indicate that these altered neutrophils readily leave the circulation and migrate to the tissues, primarily into the spleen." The resulting decrease in the number of neutrophils in the bloodstream accounts for the characteristic neutropenia. Whether or not the neutrophils that migrate to the spleen survive there and contribute to immune responses remains unclear.

The researchers believe that the specific properties of the neutrophils produced by Duffy-negative individuals have a positive impact on innate immune responses against microbial pathogens, and that genetic variant provides its carriers with a selective advantage. "But of course, a stronger immune response can also be counterproductive, for example when the immune reaction gets out of hand, and leads to chronic inflammation and autoimmune disease," Weber points out. Researchers now want to obtain a better understanding of the effects of hematopoiesis in the absence of ACKR1 on the immune response in cancer, infectious, autoimmune and inflammatory diseases like atherosclerosis. "Our discovery is a first step towards the understanding on why diseases may take different courses in people of African ancestry. Therefore potentially different medicines should be developed to treat common diseases for individuals of African ancestry" says Rot. Scientists hope that their work should initiate further research and ultimately open the way to novel, patient group targeted therapeutic strategies for Duffy-negative individuals.
-end-


Ludwig-Maximilians-Universität München

Related Stem Cells Articles:

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.
First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.
Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.
New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.
NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.
Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.
In mice, stem cells seem to work in fighting obesity! What about stem cells in humans?
This release aims to summarize the available literature in regard to the effect of Mesenchymal Stem Cells transplantation on obesity and related comorbidities from the animal model.
TSRI researchers identify gene responsible for mesenchymal stem cells' stem-ness'
Researchers at The Scripps Research Institute recently published a study in the journal Cell Death and Differentiation identifying factors crucial to mesenchymal stem cell differentiation, providing insight into how these cells should be studied for clinical purposes.
More Stem Cells News and Stem Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.